Search

Your search keyword '"B cells -- Forecasts and trends"' showing total 39 results
Start Over Descriptor "B cells -- Forecasts and trends" Publisher right vision media
39 results on '"B cells -- Forecasts and trends"'

1. Anticancer Drugs Market Size & Share to Surpass USD 303.1 billion by 2031

Subjects
Antineoplastic agents -- Market research, B cells -- Forecasts and trends, Marketing research -- Forecasts and trends, Antimitotic agents -- Market research, Pharmaceutical industry -- Market research -- Forecasts and trends, Marketing research, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Wilmington: Transparency Market Research has issued the following news release: Transparency Market Research Inc. - The global anticancer drugs market was projected to attain US$ 140.2 billion in 2022. It [...]

Published
2023

2. The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight

Subjects
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Regeneron Pharmaceuticals Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Business -- Research, Antineoplastic agents -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: B-cell lymphoma is a diverse group of blood cancers that originate from abnormal B lymphocytes, a type of [...]

Published
2023

3. Antibody Production Market Size to Reach USD 59.1 Billion by 2032 with a CAGR of 13.2% as Per Acumen Research and Consulting

Subjects
Viral antibodies -- Forecasts and trends, B cells -- Forecasts and trends, Antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LOS ANGELES: Acumen Research and Consulting has issued the following news release: The Antibody Production Market outlook remains positive, fueled by rising disease incidence, increasing pharma R&D investments, growing biotechnology [...]

Published
2023

4. Global Cell Surface Markers Analysis Report 2023: High Uptake in Drug Discovery Applications Widens Market Prospects - Forecasts to 2030

Subjects
Drug discovery -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Cell Surface Markers: Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering. Global Cell Surface Markers Market [...]

Published
2023

5. Global Bispecific Antibody Market Report 2023: Players Include Astellas Pharma, AstraZeneca, BioAtla, BJ Bioscience and EpimAb Biotherapeutics

Subjects
AstraZeneca PLC -- Forecasts and trends, Biological products -- Forecasts and trends, Viral antibodies -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, B cells -- Forecasts and trends, Drug approval -- Forecasts and trends, Antibodies -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023' report has been added to ResearchAndMarkets.com's offering. Report Highlights: [...]

Published
2023

6. Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023

Subjects
Biological products -- Product development, Viral antibodies -- Forecasts and trends, B cells -- Forecasts and trends, Drug approval -- Forecasts and trends, Antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global Bispecific Antibody Market Opportunity and Clinical Trials Insight 2023' report has been added to ResearchAndMarkets.com's offering. Report Highlights: [...]

Published
2023

7. Leukapheresis Market Report (2023 to 2031) - Kaneka Corporation, Medica SPA, Miltenyi Biotec, Macopharma, and Terumo BCT, Inc

Subjects
Kaneka Corp. -- Forecasts and trends, Leukemia -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Newark: Growth Plus Reports has issued the following news release: Growth Plus Reports estimated the size of the global market for leukapheresis in 2022 to be worth US$ 64.7 Million, [...]

Published
2023

8. Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis

Subjects
Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Regeneron Pharmaceuticals Inc. -- Forecasts and trends, Incyte Corp. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Business -- Research, Immunotherapy -- Forecasts and trends, B cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Next-Generation Immunotherapies Competitive Landscape report delivers an in-depth understanding of the next-generation immunotherapies and the next-generation immunotherapies [...]

Published
2023

9. Propulsion of Acute Lymphocytic Leukemia Pipeline as Novel and Extensive 160+ Therapies Likely to Enter in the Treatment Domain | DelveInsight

Subjects
Cellectis S.A. -- Forecasts and trends, Fate Therapeutics Inc. -- Forecasts and trends, Business -- Research, B cells -- Forecasts and trends, Acute lymphocytic leukemia -- Forecasts and trends, Industrial research -- France -- United States, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

USA: DelveInsight Business Research LLP has issued the following news release: Propulsion of Acute Lymphocytic Leukemia Pipeline as Novel and Extensive 160+ Therapies Likely to Enter in the Treatment Domain [...]

Published
2023

10. Rituximab Biosimilars Global Market Report 2023

Subjects
Amgen Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Mylan Inc. -- Forecasts and trends, Sandoz International GmbH -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Biological products -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Health care industry -- Forecasts and trends, B cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Health care industry, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Reportlinker has issued the following news release: Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. [...]

Published
2023

11. With 6.9% CAGR, Imbruvica Market Size to hit US $66.29 billion by 2030 - Price Trends, Value Chain Analysis, Challenges, Growth Drivers, and Future Business Opportunities- Adroit Market Research

Subjects
Health care reform -- Forecasts and trends, Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Chronic diseases -- Forecasts and trends, B cells -- Forecasts and trends, Marketing research -- Forecasts and trends, Marketing research, Market trend/market analysis, General interest, News, opinion and commentary, Imbruvica (Medication) -- Market research
Abstract

Dallas: Adroit Market Research has issued the following press release: The adoption of sedentary lifestyles that increase obesity rates and the development of chronic diseases like cancer, diabetes, and cardiovascular [...]

Published
2022

12. Global Immuno-Oncology Diagnostics Markets 2022-2026: Shifting Role of Diagnostics, Multiplexing and Foundation One, The Disruption Dynamic, The Race for Biomarkers, The Next Five Years

Subjects
Genomics -- Forecasts and trends, B cells -- Forecasts and trends, Instrument industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized Forecasting/Analysis 2022 - 2026' report has been added to [...]

Published
2022

13. 3D Cell Culture Market to reach 6.47 billion in 2030 with a CAGR of around 16.3%

Subjects
B cells -- Forecasts and trends, Marketing research -- Forecasts and trends, Marketing research, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: STRATEGIC MARKET RESEARCH LLP has issued the following press release: 3D cell culture is regarded as an artificially created environment where the biological cells are allowed to grow [...]

Published
2022

14. Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others

Subjects
T cells -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report has been added to [...]

Published
2022

15. Global T-cell Lymphoma Market Report to 2028 - Size, Share, Outlook, and Opportunity Analysis

Subjects
T cells -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report has been added to [...]

Published
2022

16. $2.34 Billion Viral Vector and Plasmid DNA Manufacturing Markets, 2027

Subjects
FUJIFILM Holdings Corp. -- Forecasts and trends, DNA -- Forecasts and trends, B cells -- Forecasts and trends, Vaccines -- Forecasts and trends, Genetic vectors -- Forecasts and trends, Photographic industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Viral Vector and Plasmid DNA Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)' report has [...]

Published
2022

17. Global Immuno-Oncology Diagnostics Markets, 2022-2027: Outcome Potential, Companion Diagnostics, Funding, Technology Environment, & Target Solutions Driving Growth

Subjects
Genomics -- Forecasts and trends, B cells -- Forecasts and trends, Instrument industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates' report has been added to ResearchAndMarkets.com's offering. Diagnostics, companion [...]

Published
2022

18. Global Immuno-Oncology Diagnostics Markets, 2022-2027 with COVID-19 Impact and Updates

Subjects
Genomics -- Forecasts and trends, B cells -- Forecasts and trends, Instrument industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates' report has been added to ResearchAndMarkets.com's offering. Diagnostics, companion [...]

Published
2022

19. Global Cell Surface Markers Market to 2026 - Rising Cancer Incidence Worldwide Spurs Demand For Cell Surface Markers

Subjects
B cells -- Forecasts and trends, Cancer -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Cell Surface Markers - Global Market Trajectory & Analytics' report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 [...]

Published
2022

20. Gene Editing beyond CRISPR Market : Industry Trends and Global Forecasts, 2022-2035

Subjects
Zinc finger proteins -- Forecasts and trends, Genomics -- Forecasts and trends, B cells -- Forecasts and trends, Nucleases -- Forecasts and trends, Genetic engineering -- Forecasts and trends, Marketing -- Forecasts and trends, Genetically modified organisms -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: ReportLinker has issued the following news release: Reportlinker.com announces the release of the report 'Gene Editing beyond CRISPR Market : Industry Trends and Global Forecasts, 2022-2035' - https://www.reportlinker.com/p06243858/?utm_source=GNW [...]

Published
2022

21. Granulomatosis with Polyangiitis Market to Grow at an Impressive CAGR of 27.03% During the Study Period [2018-2030], Asserts DelveInsight

Subjects
Biogen Idec Inc. -- Forecasts and trends -- Market research, Biological products industry -- Market research -- Forecasts and trends, Business -- Research, Wegener's granulomatosis -- Forecasts and trends, B cells -- Forecasts and trends, Marketing research -- Forecasts and trends, Epidemiology -- Forecasts and trends, Belimumab -- Market research, Pharmaceutical industry -- Market research -- Forecasts and trends, Marketing research, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'Granulomatosis with Polyangiitis Market' report provides a thorough comprehension of the Granulomatosis with Polyangiitis historical and forecasted [...]

Published
2022

22. Clinical Trials with LAG 3 Inhibitors Research Intelligence

Subjects
Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, T cells -- Forecasts and trends, B cells -- Forecasts and trends, Dendritic cells -- Forecasts and trends, Clinical trials -- Forecasts and trends, Drug approval -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Delhi, : Global LAG 3 Inhibitors Trials Intelligence Report Highlights: Global LAG 3 Inhibitors Market Dynamics Clinical Approaches to Target LAG 3 Inhibitors Role of LAG 3 Inhibitors in Cancer, [...]

Published
2021

23. CD233 Inhibitors Clinical Trials Market Opportunity Insight 2028

Subjects
B cells -- Forecasts and trends, Drug approval -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Delhi: KuicK Research has issued the following news release: Global CD233 Inhibitors Trials Intelligence Report Highlights: Global CD233 Inhibitors Market Dynamics Clinical Approaches to Target CD233 Inhibitors Role of CD233 [...]

Published
2021

24. 2021 Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

Subjects
United States. Food and Drug Administration, Gilead Sciences Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biological products industry -- Forecasts and trends, T cells -- Forecasts and trends, Antigens -- Forecasts and trends, B cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2021

25. The Global Research Antibodies Market Size is Expected to Reach USD 5.9 Billion by 2028 Expanding at a CAGR of 6.4%

Subjects
Biological products -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, B cells -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type (Monoclonal Antibodies, Polyclonal [...]

Published
2021

26. Global Research Antibodies Market Drivers 2021-2028 Include Rise In The Availability Of Technologically Advanced Products and a Rise In Proteomics And Genomics Research

Subjects
Biological products -- Forecasts and trends, B cells -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type (Monoclonal Antibodies, Polyclonal [...]

Published
2021

27. Allergy Treatment Market Size to Reach Revenues of USD 28.83 Billion by 2026 - Arizton

Subjects
Immunotherapy -- Forecasts and trends, B cells -- Forecasts and trends, Allergic reaction -- Forecasts and trends, Allergy -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: Arizton Advisory & Intelligence has issued the following news release: In-depth analysis and data-driven insights on the impact of COVID-19 included in this global allergy treatment market report. The [...]

Published
2021

28. A Robust Neuromyelitis Optica Spectrum Disorder Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical Development Expected to Enter the Market by the Next Decade

Subjects
Business -- Research, Neuromyelitis optica -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Los Angeles: DelveInsight Business Research LLP has issued the following news release: A Robust Neuromyelitis Optica Spectrum Disorder Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of [...]

Published
2021

29. Chronic Lymphocytic Leukemia (CLL) Report 2021: Treatments, Epidemiology, Marketed Drugs, Pipeline Drugs, Regulatory Events, Clinical Trials, Drug Assessment, Future Trends

Subjects
B cells -- Forecasts and trends, Chronic lymphocytic leukemia -- Forecasts and trends, Epidemiology -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Calquence (Medication)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Chronic Lymphocytic Leukemia (CLL)' report has been added to ResearchAndMarkets.com's offering. The publisher estimates that in 2018, there were [...]

Published
2021

30. Global CAR-T Cell Therapy Market Report 2021 - Size, Forecasts, Trials & Trends

Subjects
T cells -- Forecasts and trends, Immunotherapy -- Forecasts and trends, B cells -- Forecasts and trends, Cancer -- Care and treatment, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2021' report has been added to ResearchAndMarkets.com's [...]

Published
2021

31. China Rituximab Market Report 2021-2025: A Monoclonal Antibody to Target Cells that have the CD20 Marker on their Surface

Subjects
Genentech Inc. -- Forecasts and trends -- Market research, Biotechnology industry -- Forecasts and trends -- Market research, B cells -- Forecasts and trends, Marketing research -- Forecasts and trends, Marketing research, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Investigation Report on China's Rituximab Market 2021-2025' report has been added to ResearchAndMarkets.com's offering. According to this market research, [...]

Published
2021

32. Global Immuno-Oncology Diagnostics Market Report 2021-2025: Outcome Potential|Companion Diagnostics|Funding|Technology Environment|Target Solutions

Subjects
Myriad Genetics Inc. -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, B cells -- Forecasts and trends, Cancer -- Care and treatment, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, Including Executive/Consultant Guides and Customized Forecasting/Analysis - [...]

Published
2021

33. Global Natural Killer Cell Therapies Competitive Landscape, Technology, and Pipeline Analysis | DelveInsight

Subjects
Business -- Research, Ipilimumab -- Forecasts and trends, Biotechnology industry -- Forecasts and trends -- Product development, B cells -- Forecasts and trends, Killer cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends -- Product development, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Natural Killer Cell Therapies - Competitive Landscape, Technology, and Pipeline Analysis, 2021 report presents a detailed analysis [...]

Published
2021

34. Global Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics, 2021-2025: Explosion in Immuno-Oncology Therapies Creates an Exploding Diagnostic Market

Subjects
B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 [...]

Published
2021

35. Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, Q1 2021 Edition

Subjects
B cells -- Forecasts and trends, Cancer -- Care and treatment, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 [...]

Published
2021

36. NHL Diffuse Large B Cell Lymphoma Forecast and Market Analysis 2018-2034 - CAR-T Therapies will Become the Highest-Selling Class

Subjects
Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2019

37. NHL Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 - CAR-T therapies Yescarta and Kymriah, as well as Keytruda in PMBCL Patients, Represent a New Era in DLBCL Treatment

Subjects
Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Yescarta (Medication), Kymriah (Medication), Keytruda (Medication)
Abstract

Dublin: Research and Markets has issued the following news release: The 'NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2019

38. NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

Subjects
Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Reportlinker has issued the following news release: Disease Overview Follicular lymphoma (FL) is an indolent subtype of non-Hodgkin's lymphoma (NHL). It is the second most common type of [...]

Published
2019

39. NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034 - ResearchAndMarkets.com

Subjects
Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: -The 'NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results